Alniche Life Sciences
Alniche Life Sciences is a specialty healthcare company focused on developing and commercializing innovative healthcare products to enable people to live life with greatest potential. Headquartered in New Delhi with overseas offices in North America and Africa, it aims to improve health and save lives through high-quality, affordable medicines and wellness products. The company emphasizes deep engagement with the medical fraternity, diversification into new therapy areas, and expansion into global markets. It is committed to excellence, innovation, and building trusted brands in the healthcare sector.
Industries
Nr. of Employees
medium (51-250)
Alniche Life Sciences
Products
Faropenem (oral broad‑spectrum penem antibiotic)
Oral broad‑spectrum penem‑class antibiotic active against aerobic and anaerobic gram‑positive and gram‑negative bacteria; formulated in immediate and sustained/modified‑release oral forms.
Micafungin (sterile lyophilized intravenous antifungal)
Sterile, lyophilized intravenous antifungal formulation for systemic fungal infections; supplied as a reconstitutable IV infusion.
Liposomal ferric pyrophosphate oral formulations (including mouth‑melt)
Micronized liposomal oral iron delivery systems including orodispersible/mouth‑melt presentations to improve bioavailability and patient adherence.
Pancreatin enzyme formulations (pancreatic enzyme replacement)
Oral pancreatic enzyme preparations containing lipase, amylase and protease to aid digestion in pancreatic insufficiency or related disorders.
Multivitamin and prebiotic/probiotic combination (gut health supplement)
Oral multivitamin/mineral formulation combined with prebiotic and probiotic agents to support intestinal flora and nutrient balance, especially during acid‑suppressive therapy.
Mesalazine (5‑aminosalicylic acid) formulations for inflammatory bowel disease
Oral and rectal formulations of mesalazine for treatment of mild to moderate inflammatory bowel disease.
Faropenem (oral broad‑spectrum penem antibiotic)
Oral broad‑spectrum penem‑class antibiotic active against aerobic and anaerobic gram‑positive and gram‑negative bacteria; formulated in immediate and sustained/modified‑release oral forms.
Micafungin (sterile lyophilized intravenous antifungal)
Sterile, lyophilized intravenous antifungal formulation for systemic fungal infections; supplied as a reconstitutable IV infusion.
Liposomal ferric pyrophosphate oral formulations (including mouth‑melt)
Micronized liposomal oral iron delivery systems including orodispersible/mouth‑melt presentations to improve bioavailability and patient adherence.
Pancreatin enzyme formulations (pancreatic enzyme replacement)
Oral pancreatic enzyme preparations containing lipase, amylase and protease to aid digestion in pancreatic insufficiency or related disorders.
Multivitamin and prebiotic/probiotic combination (gut health supplement)
Oral multivitamin/mineral formulation combined with prebiotic and probiotic agents to support intestinal flora and nutrient balance, especially during acid‑suppressive therapy.
Mesalazine (5‑aminosalicylic acid) formulations for inflammatory bowel disease
Oral and rectal formulations of mesalazine for treatment of mild to moderate inflammatory bowel disease.
Services
Negotiation and management of in‑licensing agreements and global alliances to introduce foreign‑developed specialty products into domestic markets.
Hospital‑targeted product marketing and sales execution for specialty therapy areas supported by a nationwide field force and distribution network.
On‑site manufacturing capabilities to support production of pharmaceutical and life‑science products including sterile injectables and speciality dosage forms.
Provision of patient education channels, a health information portal, a mobile health application and an internal training portal for field teams.
Nationwide logistics and distribution services supporting product availability at thousands of distribution points.
Negotiation and management of in‑licensing agreements and global alliances to introduce foreign‑developed specialty products into domestic markets.
Hospital‑targeted product marketing and sales execution for specialty therapy areas supported by a nationwide field force and distribution network.
On‑site manufacturing capabilities to support production of pharmaceutical and life‑science products including sterile injectables and speciality dosage forms.
Provision of patient education channels, a health information portal, a mobile health application and an internal training portal for field teams.
Nationwide logistics and distribution services supporting product availability at thousands of distribution points.
Expertise Areas
- Specialty pharmaceuticals commercialization
- Hospital and critical‑care therapeutics
- Anti‑infective and antibiotic therapy development
- Renal care and renal nutrition products
Key Technologies
- Parenteral formulation and lyophilization
- Liposomal encapsulation for oral delivery
- Orodispersible/mouth‑melt formulation technology
- Fixed‑dose combination and modified‑release oral formulation